VeriMomSollte ich cannabidiol - synthetically produced in der Schwangerschaft meiden? | VeriMom
Evidence from animal and human-relevant studies shows cannabidiol (CAS 13956-29-1) transfers to the fetus and accumulates in fetal tissues in rodent models, and authorities have raised reproductive concerns (ANSES proposal and multiple C&L notifications listing H361), so reproductive hazard is 'suspected' rather than confirmed. SCCS evaluated CBD for cosmetic use and provided a dermal safe limit (0.19%), indicating risk is dose/exposure dependent; dermal absorption is measurable at cosmetic use levels. Sources: SCCS opinion, rodent PK study, ANSES position, ECHA C&L notifications.
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- Ist cannabidiol - synthetically produced in der Schwangerschaft sicher?
- Evidence from animal and human-relevant studies shows cannabidiol (CAS 13956-29-1) transfers to the fetus and accumulates in fetal tissues in rodent models, and authorities have raised reproductive concerns (ANSES proposal and multiple C&L notifications listing H361), so reproductive hazard is 'suspected' rather than confirmed. SCCS evaluated CBD for cosmetic use and provided a dermal safe limit (0.19%), indicating risk is dose/exposure dependent; dermal absorption is measurable at cosmetic use levels. Sources: SCCS opinion, rodent PK study, ANSES position, ECHA C&L notifications.
- Ist cannabidiol - synthetically produced während des Stillens sicher?
- Regulatory and public-health authorities advise against CBD use while breastfeeding because cannabinoids can be transferred to infants (authoritative guidance from FDA and reviews), and animal data show developmental effects; mechanism evidence includes demonstrated maternal–infant transfer and pharmacologic activity in offspring. Measured systemic exposure after dermal use is generally low but nonzero, so breastmilk exposure from topical products is plausible at higher maternal systemic levels.
- Ist cannabidiol - synthetically produced sicher für Babyhaut?
- Do not increase hazard/mechanism without infant-specific data, but increase exposure score for infant skin because infant epidermal barrier immaturity and higher surface-area-to-weight make absorption relatively greater. Given demonstrated maternal–fetal transfer and animal developmental effects, CBD remains a suspected reproductive/developmental hazard for infants if systemic exposure occurs.
- Wie bewertet VeriMom cannabidiol - synthetically produced?
- VeriMom bewertet cannabidiol - synthetically produced mit 20/100 (hohes Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu cannabidiol - synthetically produced?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu cannabidiol - synthetically produced basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.